Steep drop in enrollment of Black and Hispanic med students after Supreme Court ruling

New data reflect the first group of medical students selected since the court banned the consideration of race in admissions.

January 9, 2025 Check out STAT+

Sponsored By

Adobe Medical schools report steep drop in enrollment of Black and Hispanic students after Supreme Court ruling The new data reflect the first group of medical students selected since the court banned the consideration of race in admissions By Usha Lee McFarling Want to start a fight among virus experts? Ask about HIV's new name To impose order on burgeoning viral world, taxonomists coin "Lentivirus humimdef1" and other novelties. Researchers aren't happy. By Jason Mast STAT+ | Obesity startup Verdiva, seeing opportunity in a crowded market, raises $400M Series A The new company did not develop its own pipeline, but rather licensed its collection of compounds from the Chinese firm Sciwind Biosciences. By Andrew Joseph Ksenia Kuleshova for STAT STAT+ | German research team's discoveries open new possibilities for patients with autoimmune diseases German researchers, led by Georg Schett, achieved lupus remissions using CAR-T therapy, offering new hope for other autoimmune disease treatments. By Andrew Joseph Opinion: Too many doctors don't know how to address eating disorders Medical providers, not mental health professionals, are often the first — and sometimes only — stop for patients with eating disorders. By Deborah R. Glasofer and Evelyn Attia STAT+ | FDA pushes makers of AI devices to disclose more details on testing, performance The FDA wants the developers of medical devices that rely on AI to disclose more detail about how their devices were developed and tested. By Casey Ross Alex Hogan/STAT STAT+ | Another 'JPM Week' nears: Here's my roadmap for biotech's annual SF gathering Starting Sunday, the biopharma world descends on San Francisco for a nonstop week of presentations, closed-door meetings, and more. By Adam Feuerstein Pharma's big patent cliff, more obesity fundraising, and a failed ALS study STAT reporters discuss why a looming patent cliff could lead to more pharmaceutical deal-making and a new obesity startup. By Elaine Chen, Allison DeAngelis, and Adam Feuerstein

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser